Home › Neurologic Diseases › Pennsylvania › Philadelphia
Neurologic Diseases clinical trials in Philadelphia, PA
7 studies for Neurologic Diseases are looking for participants at sites in and around Philadelphia (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Pilot Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368, a FAAH/MAGL Inhibitor, in Participants With Post-Stroke Spasticity (The STIPS Study)
RecruitingPhase 2
- Jeffersi=on Moss Magee Rehabilitation, Elkins Park · 9 mi away
An Open-Label Exploratory Study of Fosigotifator in Participants With Vanishing White Matter Disease
RecruitingPhase 1/2
- Children's Hospital of Philadelphia, Philadelphia
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
RecruitingPhase 2
- Pennsylvania Hospital, Philadelphia
Product Surveillance Registry
RecruitingObservational study
- Philadelphia, Philadelphia
A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
RecruitingPhase 2
- Clinical Site, Philadelphia
Rett Syndrome Registry
RecruitingObservational study
- Children's Hospital of Philadelphia, Philadelphia
Epilepsy Learning Healthcare System (ELHS)
RecruitingObservational study
- Children's Hospital of Philadelphia (CHOP), Philadelphia
About Neurologic Diseases
Your nervous system includes your brain, spinal cord, and nerves. Learn about neurologic diseases, including their symptoms, causes, and treatments.
More about Neurologic Diseases on MedlinePlus
Neurologic Diseases trials in other cities
- Boston, MA10 studies
- Washington, DC8 studies
- Dallas, TX7 studies
- Orlando, FL7 studies
- Miami, FL7 studies
- New York City, NY6 studies
- Houston, TX6 studies
- St. Louis, MO6 studies
- Chicago, IL6 studies
- San Diego, CA6 studies
- Pittsburgh, PA5 studies
- Austin, TX5 studies
Other studies in Philadelphia
- Cancer (all types)59 studies
- Breast Cancer56 studies
- Non-Small Cell Lung Cancer51 studies
- Metastatic Cancer46 studies
- Prostate Cancer44 studies
- Colorectal Cancer44 studies
- Ovarian Cancer44 studies
- Lung Cancer36 studies
- Acute Myeloid Leukemia34 studies
- Heart Failure31 studies
- Endometrial Cancer28 studies
- Depression26 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.